Purchases and Sales Made in Q2 2024 in Atossa Therapeutics, Inc. (ATOS)
This table provides information about the institutional ownership of Atossa Therapeutics, Inc. (ATOS) during Q2 2024. The information is specifically focused on institutions that hold shares of ATOSSA THERAPEUTICS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 13, 2024
Q2 2024
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-600- 5.19% |
$618 - $1.26K
|
11K
$8.43K
|
|
|
Aug 09, 2024
Q2 2024
|
Virtu Financial LLC
New York, NY |
SELL
|
- |
-8.82K- 10.5% |
$9.08K - $18.5K
|
75.1K
$57.8K
|
|
|
Aug 14, 2024
Q2 2024
|
Wolverine Trading, LLC
Chicago, IL |
SELL
|
- |
-25.6K- 52.25% |
$26.3K - $53.7K
|
23.4K
$18K
|
|
|
Aug 14, 2024
Q2 2024
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-44.8K- 40.26% |
$46.2K - $94.2K
|
66.5K
$51.2K
|
|
|
Aug 14, 2024
Q2 2024
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-82.5K- 77.32% |
$85K - $173K
|
24.2K
$18.6K
|
|
|
Aug 14, 2024
Q2 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-91.3K- 36.7% |
$94K - $192K
|
157K
$121K
|
|
|
Dec 26, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-95.6K- 63.91% |
$98.5K - $201K
|
54K
$41.6K
|
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-130K- 70.93% |
$134K - $272K
|
53.2K
$40.9K
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-309K- 40.4% |
$319K - $649K
|
456K
$351K
|
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-309K- 40.4% |
$319K - $649K
|
456K
$351K
|
|
|
Aug 13, 2024
Q2 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-526K- 83.67% |
$542K - $1.1M
|
103K
$79.1K
|
|
|
Aug 14, 2024
Q2 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-1M- 98.95% |
$1.03M - $2.1M
|
10.7K
$8.21K
|